2008

Statement by the President on 2008 G8 Summit: Business Wire - July 2, 2008; WASHINGTON--Rose Garden 10:31 A.M. EDT THE PRESIDENT: Good morning. Next week I m going to travel to Japan for the eighth and final G8 summit of my presidency. At recent summits, G8 countries have made pledges to help developing nations address challenges, from health care to education, to corruption. Now we need to sh
CytoDyn Begins GMP Manufacturing of Its First-In-Class AIDS Drug: Business Wire - July 2, 2008; LOS ANGELES--CytoDyn, Inc. (Pink Sheets: CYDY) has begun GMP manufacturing and humanization of Cytolin(C), a monoclonal antibody that uses the human immune system to control HIV infection. The murine version of this product, for which there is already considerable human experience, will be used for a fast, randomized,
Press Briefing on the President's Trip to Japan and the G8 Summit: Business Wire - July 1, 2008; -- Press Briefing by National Security Council Senior Director for Asian Affairs, Dennis Wilder; Assistant to the President for International Economic Affairs, Dan Price; and Chairman of the Council on Environmental Quality, James Connaughton on the President s Trip to Japan and the G8 Summit LITTLE ROCK, Ark.--Jam
Aethlon Medical Announces Second HIV/AIDS Treatment Site: Business Wire - July 1, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India . Aethlon previously disclosed plans to initiate the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), which cau
RED to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa: Business Wire - June 30, 2008; Led by Don MacKinnon, Founder of Hear Music NEW YORK--In the fall of 2008, (RED) will unveil a simple, seamless way for people to receive music from artists they love and artists they will discover through (RED). By applying the (RED) idea to music this new model will create a new revenue stream for artists and labels
Diagnostic HYBRIDS Receives Third Frontier Grant for Development of Assays to Monitor Drug Resistance and Vaccine Production: Business Wire - June 27, 2008; ATHENS, Ohio--Diagnostic HYBRIDS has received funding through the Biomedical Research Commercialization Program (BRCP) to develop more sensitive and affordable assays for the monitoring of patients infected with Human Immunodeficiency Virus (HIV) and/or Hepatitis C Virus (HCV) and to produce vaccines against influenza
AIDS Healthcare Foundation: Criticism Mounts as CDC Delays Stark New HIV Data: Business Wire - June 26, 2008; -- Lancet Editorial, Remarks by Dr. Anthony Fauci Raise New Questions on HIV Numbers; Actions Highlight Failure of US HIV Prevention Efforts as CDC Continues to Stonewall Release of Crucial Data Expected to Show Far Higher Incidence of HIV Nationwide WASHINGTON--AIDS Healthcare Foundation (AHF) is calling upon the Cent
Allion Healthcare Announces Results of Annual Shareholders Meeting: Business Wire - June 26, 2008; MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced the successful completion of it s annual meeting held on June 24, 2008 at which three new directors were elected to serve on its six member Board. The shareholders also approved the issuance of 6,125,448 shares of common stock reflecting the one-for-one c
Remarks by the President at Office of Faith-Based and Community Initiatives' National Conference: Business Wire - June 26, 2008; WASHINGTON--Omni Shoreham Hotel 12:59 P.M. EDT THE PRESIDENT: Thank you very much. Please be seated. (Applause.) How beautiful was that? From being a homeless mother of two to introducing the President of the United States . (Applause.) There has to be a higher power. I love being with members of the armies of compassi
Statement by Mrs. Laura Bush: Business Wire - June 26, 2008; WASHINGTON--National HIV Testing Day is an opportunity for Americans to increase their awareness of HIV/AIDS and get tested. More than one million Americans have HIV - and a quarter of them don t even know it. Through the Ryan White HIV/AIDS program, HIV/AIDS patients can receive treatment, including life-saving drugs,
OraSure Technologies and the National Association of People with AIDS Will Open the NASDAQ Stock Market on June 27 in Observance of National HIV Testing Day: Business Wire - June 26, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) and the National Association of People with AIDS (NAPWA) announced today that OraSure officials will be joined by Frank Oldham, Jr., President and CEO of NAPWA, and the Honorable Johnny Ford, Mayor of Tuskegee, Alabama and Director General of the World Conference
Cytheris Announces Publication of IL-7 Oncology Data in The Journal of Experimental Medicine: Business Wire - June 26, 2008; -- Results of a Second Phase 1 Trial in Oncology Further Demonstrate the Potential of Interleukin-7 To Induce Dramatic and Prolonged CD4 and CD8 T Cell Expansion PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the
Press Briefing by Dana Perino: Business Wire - June 25, 2008; WASHINGTON--James S. Brady Press Briefing Room 12:38 P.M. EDT MS. PERINO: Hello. One announcement for you. Tomorrow President Bush will deliver remarks at the Office of Faith-Based and Community Initiatives National Conference. During his speech he will highlight the Initiative s record of helping millions in need acro
Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL® in Women Ages 27 through 45: Business Wire - June 25, 2008; WHITEHOUSE STATION, N.J.-- Merck & Co. , Inc. announced today that the US Food and Drug Administration ( FDA ) has issued a complete response letter regarding the supplemental biologics license application (sBLA) for the use of GARDASIL® in women ages 27 though 45. The agency issued the letter to advise that it has
European Nucleic Acid-Based Amplification Reagents Markets for Clinical Applications: Business Wire - June 24, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/33e995/european_nucle ic_a) has announced the addition of Frost & Sullivan s new report European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications to their offering. Research Overview: This Frost & Sulliv
Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development announce five-year collaboration targeted to accelerate TB treatment R&D: Business Wire - June 24, 2008; -- The NITD and the TB Alliance s collaboration aims to move projects quickly from the research phase through the translational stage and into development Both partners will leverage their broad networks of expertise and resources to rapidly bring effective, simpler treatments to patients NEW YORK--The Global Alliance
Aethlon Medical Announces "First-In-Man" HIV/AIDS Treatment Study: Business Wire - June 24, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has entered into an agreement to initiate the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV) which causes Acquired Immune Deficiency Syndrome (AIDS). The Aethlon Hemopurifier(R) is a medical device cre
Minnesota AIDS Project Recognizes National HIV Testing Day: Challenges Minnesotans to Know Their Status: Business Wire - June 23, 2008; MINNEAPOLIS--On June 27, in cities throughout the United States , organizations will mark National HIV Testing Day to encourage everyone to receive voluntary HIV testing and counseling to know his or her status. The Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, offers risk as
65 U.S. Mayors to Join OraSure Technologies and the National Association of People with AIDS in Fourth Annual 'Mayors Campaign against HIV™' for National HIV Testing Day: Business Wire - June 23, 2008; -- Record Number of U.S. Mayors Unite to Promote HIV Screening on June 27th BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ: OSUR) and the National Association of People with AIDS (NAPWA) announced today that more than 65 mayors and/or Department of Health offices in major metropolitan cities nationwide have committ
Mexican AIDS Activists March to Demand National State of Emergency Over Drug Prices and Access in Mexico: Business Wire - June 20, 2008; -- AIDS Healthcare Foundation Joins Over 60 Groups in Mexican AIDS Drug Advocacy Coalition; Marchers Call on Mexico s Secretary of Health to Step Up Action on AIDS Treatment and Drug Pricing MEXICO CITY--A group of over 150 AIDS Mexican advocates and activists held a passionate protest and advocacy march yesterday in M
Sybase 365 Supports Nelson Mandela Charities Launch of International SMS Campaign: Business Wire - June 19, 2008; -- Global Birthday Wishes Campaign for Mr. Mandela s 90th Birthday is First Truly Global Charity PSMS Service Ever Launched DUBLIN, Calif.--Sybase 365, a subsidiary of Sybase, Inc. (NYSE:SY), the global leader in mobile messaging services, today announced it has partnered with 46664, Nelson Mandela s HIV/AIDS global aw
2008 Presidential Medal of Freedom Citations: Business Wire - June 19, 2008; WASHINGTON--Today President George W. Bush awarded the Presidential Medal of Freedom to six individuals. The text of each recipient s citation reads as follows: Benjamin S. Carson, Sr., M.D. Dr. Benjamin Carson is a pioneer in pediatric neurosurgery, and his life is a testament to the power of education, hard work, and
Lab Express Offers $25 HIV Screening in Honor of National HIV Testing Day: Annual Test Recommended for Singles Who Are Sexually Active: Business Wire - June 18, 2008; PHOENIX--Lab Express, Arizona s largest independent medical testing company, is cutting the cost of their 10 minute HIV screening to just $25 (typically $89) from June 23rd to June 27th in honor of National HIV Testing Day. Doctors recommend that anyone who is sexually active and not in a monogamous relationship should
GRANT ANNOUNCEMENT: M·A·C AIDS Fund South Africa Marks Largest Ever One-Time Gift with One Million Rand to Local Charities: Business Wire - June 18, 2008; --Grant-Making Part of Week-long Giving, HIV Awareness Activities in Region from Top Global Funder --MAF: WHAT Two South African AIDS charities received a boost from the M·A·C AIDS Fund with the announcement today of two 500 000R grants, the single largest one-time gift from the South Africa affiliate of the global fun
Community Leaders Forge New Approach to HIV Prevention as Part of M·A·C AIDS Fund Leadership Initiative: Business Wire - June 18, 2008; --Twelve S. Africans Bring Columbia University, UCLA Fellowship Training to Local AIDS Programs; Gather in Johannesburg to Discuss Stigma, Gender Inequality --M·A·C AIDS Fund Marks $125M in Global Giving JOHANNESBURG, South Africa--HIV among imprisoned juveniles, teenagers and the Muslim community headlined a discussio
Spectrum Pharmaceuticals Announces FUSILEV(TM) as Tradename for Levoleucovorin for Injection: Business Wire - June 17, 2008; * FUSILEV(TM) Launch Expected in Mid-August 2008 * FUSILEV(TM) NDA Approved by the FDA On March 7th, 2008 IRVINE, Calif.--Spectrum Pharmaceuticals, Inc., (NasdaqGM: SPPI) today announced the selection of FUSILEV(TM) (levoleucovorin) for injection as the trade name for levoleucovorin, the company s proprietary drug whic
Nationwide Data Indicate a Very High Degree of Accuracy for OraQuick ADVANCE Rapid HIV-1/2 Antibody Test with Oral Fluid: Business Wire - June 16, 2008; -- Nationwide Accuracy for 2007 Through May 2008 of 99.8% Reported From Over 400 Testing Sites and More Than 250,000 Tests BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that aggregate nationwide performance data for 2007 and the first five months of 2008 indicate that its widely used rapid HI
NanoViricides Anti-HIV Lead Drug Candidate Demonstrated Substantial Improvement in Survival Time in Animal Model: Business Wire - June 16, 2008; -- Results Better Than Combination Therapy in Double-Blind Animal Study WEST HAVEN, Conn. -- NanoViricides, Inc. (OTC BB: NNVC.OB), (the Company ) said that its lead anti-HIV drug candidate demonstrated markedly superior survival results in the test animals when compared to those animals given the anti-HIV combo cockta
AHF to Dr. Fauci and the CDC: "Show Us the AIDS Numbers": Business Wire - June 11, 2008; -- U.S. s Largest AIDS Organization Demands Immediate Release of New AIDS Data Referred to By NIAIDS Director Dr. Anthony Fauci at U.N. AIDS Meeting Showing Higher Rate of Infection, Calls for Massive Increase in HIV Testing Nationwide NEW YORK--AIDS Healthcare Foundation (AHF) is calling for the immediate release of t
Viral Genetics Announces Expanded License with University of Colorado and V-Clip Pharmaceuticals: Progress to Date on Licensed HIV/AIDS Technology Leads to New Rights: Business Wire - June 11, 2008; AZUSA, Calif.--Viral Genetics (Pink Sheets: VRAL) subsidiary V-Clip Pharmaceuticals has expanded the existing Exclusive License Agreement with the University of Colorado by obtaining two Exclusive Option Agreements to acquire rights for treatment and detection of several forms of cancer including lung, breast, leukemia
California Scientists Sound Alarms about National Institutes of Health: Without Increased Funding, the State's Dominance and Public Health are Threatened: Business Wire - June 11, 2008; LA JOLLA, Calif.--The California Healthcare Institute (CHI) and PricewaterhouseCoopers (PwC) today released a report, The National Institutes of Health: Fueling Healthcare Innovation in California, urging legislators to support increased funding for the National Institutes of Health (NIH) – the backbone of the biomedic
Panacos to Webcast its R&D Day on Wednesday, June 18th: Business Wire - June 11, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will broadcast its Research and Development Day over the internet on Wednesday June 18, at 12:00 pm ET. The meeting and webcast will be hosted by Alan W.
Panacos Presents Bevirimat Patient Response Predictors at the International HIV Drug Resistance Workshop: Business Wire - June 11, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), today announced factors that predict treatment response to bevirimat, a novel, oral HIV maturation inhibitor. The findings were described during multiple presentations at the 17th International HIV Drug Resistance Workshop in Sitges, Spain , con
MTV and SpinVox Partner to Launch First Ever Integrated Voice Powered Cause-Related Social Networking Campaign 'Stand by What You Say': Business Wire - June 10, 2008; --Campaign Voiced by Superstar Kelly Rowland -- Causes Promotes Campaign to its 12 Million Subscribers LONDON & NEW YORK--MTV s Staying Alive Foundation, SpinVox and Causes on Facebook today announced the launch of their joint campaign, Stand by What You Say . The groundbreaking initiative encourages young people t
Micronics Receives NIH Grant to Advance Rapid Molecular Test for HIV Diagnosis: Development Effort Focuses on Point of Care Patient Testing: Business Wire - June 9, 2008; REDMOND, Wash.--Micronics, Inc., a leading provider of custom lab card design, development, and production services for the global health market, today announced that it has been awarded a $100,000 Small Business Innovation Research grant to advance its diagnostic test to detect Human Immunodeficiency Virus (HIV) at po
AHF's Public Health Division Celebrates Advances in the Fight Against HIV/AIDS with June 9th Re-Dedication Ceremony at Former Los Angeles AIDS Hospice: Business Wire - June 9, 2008; -- AHF s Chris Brownlie House, Formerly the First Licensed AIDS Hospice in the Nation, Now Serves Thousands as the Hub of US Largest AIDS Organization s Public Health Outreach, Providing HIV/STD Prevention, Testing and Counseling Services LOS ANGELES--AIDS Healthcare Foundation (AHF), operator of the largest non-govern
AIDS Thought Leaders Share Best Practices in HIV/AIDS Services Delivery as Disease Enters its Third Decade: Flowers Heritage Foundation Hosts Two Day Forum to Spur New Thinking in Addressing Epidemic: Business Wire - June 6, 2008; OAKLAND, Calif.--The Flowers Heritage Foundation, a non-profit dedicated to providing solutions for public health issues, today announced a two-day HIV/AIDS forum -- A Think Tank Experience - The Third Decade: New Directions and New Models in HIV Services -- on June 6 and June 7 in Oakland, CA. Key stakeholders and opi
OraSure Technologies to Present at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference: Business Wire - June 5, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference in New York City. The conference will be simultaneously webcast o
Remarks by President Bush and Prime Minister Jan Peter Balkenende of the Netherlands in Photo Opportunity: Business Wire - June 5, 2008; WASHINGTON--Oval Office 2:13 P.M. EDT PRESIDENT BUSH: Mr. Prime Minister, thanks for coming back. I enjoyed being with you. You represent a great country. You re a good friend of the United States of America. And I appreciate -- appreciate our candid discussion of a variety of issues. First, I want to thank you and
Remarks by the President at Ceremonial Groundbreaking of United States Institute of Peace: Business Wire - June 5, 2008; WASHINGTON--Navy Hill 10:49 A.M. EDT THE PRESIDENT: Thank you, all. Please be seated. Mr. Secretary, thank you for your kind introduction, and thank you for inviting me to join you to break ground for the United States Institute of Peace s new home. I m really pleased to be here. I appreciate what you do to resolve con
CytoDyn to Meet with Quest Clinical Research to Finalize Phase II Strategy for Novel AIDS Drug: Business Wire - June 5, 2008; LOS ANGELES--Following a management meeting in San Francisco on June 7, representatives of CytoDyn, Inc. (Pink Sheets: CYDY) will be meeting with Principle Investigator Dr. Jay Lalezari at Quest Clinical Research to finalize the Company s strategy for a Phase II trial of Cytolin(R). An immune therapy that uses the huma
ExxonMobil Receives 2008 Malaria Award from Global Business Coalition: Nine Businesses to be Honored for Fighting Diseases: Business Wire - June 4, 2008; IRVING, Texas--Exxon Mobil Corporation (NYSE:XOM) has been awarded the 2008 Malaria Award by the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria in recognition of the corporation s Africa Health Initiative and its role in the battle against malaria. The prospects for winning the fight against global epi
Randy Jordan Begins as New CEO at HOPE worldwide: Founders Hand Over the Reins at Global Summit: Business Wire - June 4, 2008; WAYNE, Pa.--HOPE worldwide co-founders, Robert and Patricia Gempel, transferred their leadership roles to Randy Jordan , the global charity s chief operating officer, during the organization s annual Global Summit in May. Building on 12 years of senior leadership experience with HOPE worldwide, Jordan begins his new ro
South African Healthcare Industry: Emerging Trends and Future Prospects: Business Wire - June 4, 2008; PALO ALTO, Calif.--The Healthcare Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the South African healthcare industry to be held on Wednesday, June 11, 2008 at 8:00 a.m. PST. After 1994, South Africa transformed the healthcare system with a clear political comm
Avexa Collaborates With TargetDrug on HCV Program: The Company Also Provides an Update on ATC Phase III Trials: Business Wire - June 4, 2008; MELBOURNE, Australia--Australian biotechnology company Avexa Ltd (ASX:AVX) announced today that it will collaborate with TargetDrug on its Hepatitis C virus (HCV) program. The focus will be on the development of novel lead inhibitors of HCV replication. The Company also provided an update on the progress of its Apricit
Boehringer Ingelheim, Gilead Agree to AIDS Drug Price Freeze: Business Wire - June 3, 2008; -- AIDS Healthcare Foundation Urges Drug Giants Merck, Tibotec, Pfizer and Others to Follow Suit, Suspend Price Increases and Expand Access to Lifesaving Antiretroviral Medications LOS ANGELES--AIDS Healthcare Foundation (AHF) -- the largest US-based AIDS organization and operator of free AIDS treatment clinics in the
Vertex Pharmaceuticals Sells HIV Product Royalty Stream for $160 Million: Business Wire - June 3, 2008; CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has sold its rights to future royalties in Lexiva(R) and Agenerase (R) under its 1993 license agreement with GlaxoSmithKline plc (GSK) in the field of HIV protease inhibitors
Search for an HIV Vaccine Continues Despite Setbacks: Fitness & Health III, Wellness: Business Wire - June 3, 2008; --A mood of deep pessimism has spread among the international community of AIDS scientists following last year s trial failure of a promising Merck vaccine. This was only the latest in a series of setbacks in the twenty-year struggle to develop an HIV vaccine. The passion for finding an HIV vaccine resonates strongly a
AHF Cheers Washingon Post Nod to Senator Coburn (R-OK) on Saving More Lives Through PEPFAR: Business Wire - June 2, 2008; --Sunday Editorial Concedes the Senator Has a Point in Striving to Preserve the Bill s Focus on Treatment --AHF Calls for Treatment Goal Increase Equal to Funding Increase. The Results? Four Million Additional Lives Saved WASHINGTON D.C.--AIDS Healthcare Foundation (AHF), which operates free AIDS treatment clinics in t
Converse (PRODUCT) RED(TM) Debuts Its Fall/Holiday 2008 Converse 1HUND(RED) Artists and African Canvas Footwear Collections: Business Wire - June 2, 2008; -- Converse s Year-Long Global Curation Project Includes Limited Edition Designed Shoes And MAKE MINE RED Design-Your-Own Options In Support of Converse (PRODUCT) RED NORTH ANDOVER, Mass.--Converse debuts the second 1HUND(RED) Artists footwear collection for Fall/Holiday 2008, the brand s unprecedented year-long global
VIRxSYS Presents New VRX496 Phase II HIV Gene Therapy Trial Data: Update at American Society of Gene Therapy Annual Meeting: Business Wire - May 30, 2008; GAITHERSBURG, Md.--VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, will present additional results from its Phase II trial of VRX496, an investigational gene therapy for the treatment of AIDS, at the 2008 American Society of Gene Therapy Annual Meeting in Boston, Ma
'Shame on Merck': Drug Giant Blasted for Steep AIDS Drug Prices in Mexico in New US Print Ad Campaign by AHF: Business Wire - May 29, 2008; --Newspaper Ads in New Jersey, New York s Village Voice and the Washington Blade Criticize Merck for Charging Mexico Six Times More Than Other Latin American Countries for its Key AIDS Drug, Stocrin LOS ANGELES--As part of its ongoing campaign to lower drug prices and improve access to lifesaving AIDS treatments global
Yissum Introduces Novel Device for Improved Saliva Based Medical Diagnostics: Technology Presented at ILSI BioMed Israel 2008 conference - ILSI-Biomed Israel 2008: Business Wire - May 27, 2008; TEL AVIV, Israel-- Yissum, the technology transfer company of the Hebrew University of Jerusalem, introduced today a novel device that enhances the diagnostic value of saliva. Speaking at the Technology Transfer Session at the ILSI Biomed Israel 2008 conference Professor Aaron Palmon, from the Faculty of Dental Medicin
Inovio Biomedical Licenses Electroporation Delivery Technology to Leading U.S. Government Contractor, Advanced BioScience Laboratories, Inc.: License Anticipated to Aid the Development of DNA Vaccines for Chronic Infectious Diseases and Cancer: Business Wire - May 27, 2008; SAN DIEGO-- Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that it has entered into a license agreement with Advanced BioScience Laboratories, Inc. (ABL) so that ABL may provide advanced electroporation delivery of
$50 Billion Needed for Global AIDS Control: Commentary by AIDS Healthcare Foundation President Michael Weinstein: Business Wire - May 23, 2008; WASHINGTON--As Congress considers the renewal of PEPFAR (the President s Emergency Plan for AIDS Relief), the successful US global AIDS program, over the coming weeks, AIDS Healthcare Foundation (AHF) President Michael Weinstein offers the following commentary regarding what is needed in the global fight against HIV/AI
National Education Summit to Tackle African-American HIV/STD Crisis: Business Wire - May 22, 2008; ALEXANDRIA, Va.--Black state board of education leaders from across the nation will meet to strategize about ways in which public schools can help address the HIV and STD crises among African-Americans and to highlight the clear link between risky sexual behaviors and academic performance on May 28-30, 2008 in Atlanta,
Independent Forecasts and Competitive Intelligence on Estonia's Pharmaceuticals and Healthcare Industry: Business Wire - May 22, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c92547) has announced the addition of Estonia Pharmaceuticals and Healthcare Report Q2 2008 to their offering Poor healthcare has been seen as a weak link in Estonia s 15-year post-Soviet economic miracle , although the government has mad
Immunicon Corporation Presented Advances in Rare Cell Technology at ISAC XXIV International Congress, May 17-21, 2008: Business Wire - May 21, 2008; -- Presentations Highlight Advances in Rare Cell Image Cytometry in the Areas of HIV Monitoring, Identifying RSV Infections, Improved Detection of Circulating Tumor Cells and Automated F.I.S.H. Counting. HUNTINGDON VALLEY, Pa. & BUDAPEST, Hungary--Immunicon Corporation (OTCBB:IMMC) made several presentations at the
TherapyEdge (ABL group) and TCELS To Cooperate for the National HIV/AIDS Surveillance Program in Thailand Using The TherapyEdge-ViroScore System: Business Wire - May 20, 2008; LUXEMBOURG--The multi-centre and prospective surveillance program of HIV drug resistance emergence and transmission in Thailand starts in 2008 The Thailand Centre of Excellence for Life Sciences (TCELS, Bangkok (Thailand)), TherapyEdge Inc. (TE; Boston (MA)) and Advanced Biological Laboratories (ABL), S.A (
Samaritan's Last-Ditch Salvage Therapy SP-01A Fighting "HIV Drug Resistance," Issued US Patent: Business Wire - May 20, 2008; -Phase II Clinical Trials Prove Potent Activity for SP-01A as Salvage Therapy to Treat Ever Increasing HIV Drug Resistance -Patent Covers, 1. Composition of Anti-HIV Drugs and Anti-Cortisol Compounds and 2. Method for Decreasing the Side Effects of Anti-HIV Drugs in Humans LAS VEGAS--(BUSINESS WIRE)--Samaritan Pharmace
Fixed-Dose Combination Drugs for Leading Diseases Report Provides a Discussion of the History and Advantages of Fixed-Dose Combination Drug Products: Business Wire - May 20, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c92368) has announced the addition of The Global Market for Fixed-Dose Combination Drugs for Leading Diseases to their offering. The Global Market for Fixed-Dose Combination Drugs for Leading Diseases analyzes products and applications of
Nutra Pharma Subsidiary, ReceptoPharm, Receives Approval to Begin Clinical Trials for the Treatment of Feline Leukemia Virus (FeLV): Business Wire - May 19, 2008; BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, Inc., has received approval from the Florida Department of Agriculture and Consumer Services to conduct
CytoDyn Appoints Dr. Nader Z. Pourhassan Chief Operating Officer: Business Wire - May 19, 2008; LOS ANGELES--CytoDyn, Inc. (Pink Sheets:CYDY) has appointed Nader Z. Pourhassan, Ph.D., as its Chief Operating Office. Dr. Pourhassan was born in Tehran in 1963, immigrated to the United States in 1977, and became a U.S. citizen in 1991. He received his Bachelor of Science from Utah State University in 1985, his Master
Webcast to Showcase Saba Centra and The Hope Program-Globally Training Physicians in HIV Medicine: Attendees to Learn How to Facilitate Cost-Effective, Worldwide Learning and Collaboration: Business Wire - May 16, 2008; REDWOOD SHORES, Calif.--Saba (NASDAQ:SABA) the premier people management software and services provider, has announced that its customer, the HIV Online Provider Education (HOPE) Program, will be featured in an upcoming Saba Webcast titled, How Online Collaboration is Changing the World-The Use of Technology for Rapid,
AIDS Portrait Exhibit in Russell Rotunda Highlights Need to Preserve AIDS Treatment Focus in PEPFAR - 'AfricAlive: Portraits of Success': Business Wire - May 15, 2008; Despite Congress Tripling of PEPFAR Funding for Successful US Global AIDS Program, Current Re-authorization Bill Lacks Any Treatment Requirement, a Key Component to PEPFAR s Success MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5685774 --AIDS Healthcare Foundation: AfricAlive: Portraits of Succe
Allion Healthcare to Present at JMP Securities Research Conference: Business Wire - May 13, 2008; MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will participate in the Seventh Annual JMP Securities Research Conference in San Francisco, May 21, 2008. Mike Moran, Allion s Chairman, President and Chief Executive Officer will give a Company presentation on Wednesday, May 21, 2008, at 4:30 PM
Senators Support African AIDS Delegation Call to Save Seven Million Lives through PEPFAR: Business Wire - May 12, 2008; -- Congress Triples Funding for Successful US Global AIDS Program in Re-authorization Bill, but Removes Requirement that Any Money Be Spent on Treatment, a Key Component of PEPFAR s Success --Senators Will Announce Effort to Preserve Treatment Priority in Legislation and Push to Increase PEPFAR s Treatment Goals; Up On
Ramsell Public Health Rx Awarded Colorado State Pharmaceutical Assistance Program Contract: Program to Help AIDS Patients with Much Needed Pharmaceutical Assistance: Business Wire - May 12, 2008; OAKLAND, Calif.--Ramsell Public Health Rx today announced that it will administer a full suite of Pharmacy Benefit Management (PBM) solutions for the Bridging the Gap, Colorado (BTGC) program, a State Pharmaceutical Assistance Program (SPAP) that covers the costs of a participant s Medicare deductible, co-payment and c
Virostatics Doses First Patient in Phase IIa Trial of VS411 for the Treatment of HIV Infection: Business Wire - May 12, 2008; SASSARI, Italy & PRINCETON, N.J.--Virostatics, srl, a privately-held pharmaceutical company focused on the discovery and development of combination therapeutics in HIV/AIDS, virology, and other chronic diseases, today announced it has initiated dosing of subjects in its five-arm, dose-ranging, proof of principle st
Argos Therapeutics Initiates Phase 2 Proof-of-Concept Trial for its Arcelis{TM} Personalized Immunotherapy Platform in HIV: Business Wire - May 12, 2008; DURHAM, N.C.--Argos Therapeutics today announced the initiation of a Phase 2a proof-of-concept clinical trial to test the efficacy of its AGS-004 therapy in improving immune control of viral replication in HIV-infected adults. AGS-004 is a product of the Company s Arcelis{TM} technology, a personalized, RNA-loaded dend
AHF Launches "YouTube" Campaign: "Congress-Save AIDS Treatment in PEPFAR": Business Wire - May 11, 2008; -- Jenny Boyce, a Mother Living with HIV/AIDS in Durban, South Africa , Tells the Story of How Treatment Saved Her Life --Lydia Nyide Speaks About Her 11-Year-Old Granddaughter Phumla Whose Life Was Saved by Treatment WASHINGTON--Today AIDS Healthcare Foundation (AHF), launched a YouTube video to press Congress to pr
Allion Healthcare Reports First Quarter 2008 Results: Business Wire - May 8, 2008; * Net sales for the quarter increased 10.7% to a record $65.3 million * Announces Opening of New Pharmacy in Seattle with Lifelong Aids Alliance * Announces settlement of Oris Litigation MELVILLE, N.Y.--(BUSINESS WIRE)--Allion Healthcare (NASDAQ: ALLI) today announced financial results for the three months ended March
Minnesota AIDS Project to Host 21st Annual AIDS Walk and Inaugural 10K Run: Business Wire - May 8, 2008; MINNEAPOLIS--Each year, the Minnesota AIDS Project hosts the largest HIV fundraiser in the state. The 2008 Minnesota AIDS Walk on May 18th will be the 21st annual event to raise crucial funds to support ongoing advocacy efforts, prevention education, and services for those living with HIV in Minnesota. A total of 325 n
Aethlon Medical Releases Smallpox Related Research Data: Business Wire - May 8, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today disclosed that researchers have completed in vitro studies that verify the ability of the Aethlon Hemopurifier{R} to effectively capture monkeypox virus (MPV). MPV represents a primary model to study candidate therapies for smallpox virus as research with human infect
OraSure Technologies Announces 2008 First Quarter Results: Business Wire - May 6, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced quarterly revenues of $18.1 million for the three months ended March 31, 2008, compared to $20.1 million in revenues recorded for the three months ended March 31, 2007. Increased sales of the Company s O
Press Briefing by Dana Perino: Business Wire - May 6, 2008; WASHINGTON--James S. Brady Press Briefing Room 12:41 P.M. EDT MS. PERINO: Hi, how is everybody? Two announcements for you. First of all, the President is pleased that the U.S.-Russian Agreement for Cooperation in the Field of Peaceful Uses of Nuclear Energy -- also known as a 123 Agreement -- was signed today in Moscow
OC AIDS Walk Aims for Million Mark: Business Wire - May 6, 2008; ANAHEIM, Calif.--With only a week away until OC AIDS Walk at Angel Stadium of Anaheim on Saturday, May 10th, event organizers are hopeful that the Walk will far exceed its goal of $750,000. Although past years has rendered it difficult for the Walk to raise over $600,000 at its former location on the campus of UC Irvin
Washington Wines Festival Announces "Wine Weekend" to Benefit Camp Korey, Hole in the Wall Camps and Washington Wine Education Foundation: First-Time Ever Exclusive Event to Feature Music Artists Vince Gill, Amy Grant and Lisa Loeb, Renowned Chefs and 50 of the Top Wineries of Washington State: Business Wire - May 6, 2008; CARNATION, Wash.--The Washington Wines Festival announced today the 2008 Wine Weekend to benefit Camp Korey and Hole in the Wall Camps. This exclusive event featuring two days of fun, relaxation and entertainment will be held July 11 & 12, 2008 at the future site of Camp Korey at Carnation Farm and will raise funds
Aethlon Hemopurifier{R} Effective in Capturing West Nile Virus: Business Wire - May 6, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today announced that pre-clinical studies have documented that the Aethlon Hemopurifier{R} is effective in capturing circulating West Nile Virus (WNV). The study data further supports the potential use of the Hemopurifier{R} as a broad-spectrum treatment against viral patho
NEW Clorox{R} Disinfectant is EPA Registered to Kill Both Known Types of MRSA - Including Community-Associated (CA-MRSA): Clorox{R} Pro Quaternary All-Purpose Disinfectant Cleaner Offers a One-Step Germ-Killing Solution for Professionals: Business Wire - May 5, 2008; OAKLAND, Calif.--While MRSA has been an issue in healthcare settings for years, CA-MRSA outbreaks in the community have been on the rise, with the greatest risk in community settings such as fitness clubs, in sports teams, at schools and daycare centers. In May, The Clorox Company will launch Clorox{R} Pro Quaternary A
Two New Hampshire Youth Honored for Volunteerism at National Award Ceremony in Washington, D.C.: Sarah Ferguson, Duchess of York, Pays Tribute to Young Heroes as Part of Four-Day Recognition Events: Business Wire - May 5, 2008; WASHINGTON--Two New Hampshire students, Aditya Ashok, 17, of Nashua and Brianna Hartford, 14, of Littleton were honored in the nation s capital last night for their outstanding volunteer work during the presentation of The 2008 Prudential Spirit of Community Awards. The two young people - along with 100 other top youth
Two Vermont Youth Honored for Volunteerism at National Award Ceremony in Washington, D.C.: Sarah Ferguson, Duchess of York, Pays Tribute to Young Heroes as Part of Four-Day Recognition Events: Business Wire - May 5, 2008; WASHINGTON--Two Vermont students, Zoe Isaacs, 16, of Sharon and Claire Trombley, 12, of Bristol were honored in the nation s capital last night for their outstanding volunteer work during the presentation of The 2008 Prudential Spirit of Community Awards. The two young people - along with 100 other top youth volunteers
Anti-HIV NanoViricide Drug Candidate Demonstrates Significant Therapeutic Efficacy in Animal Trials: Positive Initial Results Pave the Way for Definitive Follow-Up Studies: Business Wire - May 5, 2008; WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), said that its anti-HIV drug candidates demonstrated significant therapeutic efficacy in the recently completed preliminary animal studies. The studies were performed at a Bio-Safety Level 3 Laboratory (BSL-3) facility in Boston, MA. These mouse model studies wer
Indiana Religious Leaders Urge Obama and Clinton to Overhaul Foreign Aid: Business Wire - May 2, 2008; WASHINGTON--Today, Global AIDS Alliance announced that nine senior religious leaders from Indiana called on Senators Obama and Clinton to declare their support for an urgent overhaul of US foreign aid. At least 425 US soldiers, 15 of them from Indiana, have died in Afghanistan and
HHS Contract for Technical Management, Assistance on AIDS.gov Web Site Awarded to ICF International: Firm to Help Agency Enhance Features, Implement New Tools: Business Wire - May 1, 2008; FAIRFAX, Va.--ICF International (NASDAQ:ICFI) was selected by the U.S. Department of Health and Human Services, Office of HIV/AIDS Policy, to provide technical management and assistance to maintain and enhance its AIDS.gov Web site. Under the new contract, ICF will implement new media tools such as mobile technology, e
Panacos to Present at Deutsche Bank Health Care Conference: Business Wire - May 1, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Deutsche Bank Health Care Conference to be held from May 5-7, 2008 at The InterContinental Hotel in Boston, MA. Alan W. Dunton, M.D.,
SeraCare Seroconversion Panels with Extended Stability Improve Diagnostic Testing and Anti-viral Drug Discovery Opportunities: 25-year stability data presented at 24th Annual Clinical Virology Symposium: Business Wire - April 29, 2008; MILFORD, Mass.--SeraCare Life Sciences, Inc. (SRLS:PK) today presented data demonstrating that the Company’s seroconversion panels for HIV, Hepatitis B virus (HBV) and Hepatitis C virus (HCV) remain stable for a minimum of 25 years. This extended shelf-life expands research opportunities for biopharmaceutical customers
BrowserMedia Launches New Website for The Alliance for Microbicide Development: Business Wire - April 29, 2008; BETHESDA, Md.--BrowserMedia announced today the launch of the new website for The Alliance for Microbicide Development, viewable at http://www.microbicide.org. The Alliance for Microbicide Development is the leading source for trusted information on microbicide research and development. BrowserMedia s design and inform
Allion Healthcare Appoints Chief Financial Officer: Business Wire - April 29, 2008; MELVILLE, N.Y.)--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced the appointment of Russell J. Fichera to the position of Senior Vice President and Chief Financial Officer, effective June 1, 2008. Russ brings to his new position a great base of experience in the healthcare sector, and a compelling record of lea
Spicy Pickle{TM} Teams With Dining Out for Life To Raise Funds For Project Angel Heart: Business Wire - April 29, 2008; --Spicy Pickle to Donate 25% of Sales on May 1st; Monies to be Used for Meals for People Living with Life-threatening Illnesses DENVER--The Spicy Pickle{TM} fast casual restaurant at 1298 S. Broadway today announced that 25% of their food sales on Thursday, May 1st will be donated to Project Angel Heart in support of t
Hope Blooms Eternal as New Website Brings Charitable Giving to the Facebook Generation:Hope Equity(R) revolutionizes philanthropy with one-stop charity shopping: Business Wire - April 28, 2008; LITTLE ROCK, Ark.--Facebook. MySpace. LinkedIn. The social networking trend is projected to grow by an estimated 43 percent annually over the next five years (according to Forrester Research). Now a new website is leveraging this social networking phenomenon to build online communities dedicated to helping the world ar
National Volunteer of the Year Takes to Capitol Hill This Week: Business Wire - April 28, 2008; ALEXANDRIA, Va.--Participating in AIDS Watch 2008, Catholic Charities USA s newly named National Volunteer of the Year is on Capitol Hill this week seeking a solid federal commitment to AIDS programs. Ray Suttles, a volunteer with Catholic Charities of Paterson s Hope House in New Jersey, was named Catholic Charities U
Sunday, April 27th: Actors Blair Underwood and Mario Cantone Join Thousands for Florida AIDS Walk: Business Wire - April 27, 2008; --Funds Raised Will Support Expanded HIV Testing and Statewide Medical Care --87,000 Floridians Are Infected With HIV/AIDS, South Florida Leads the Nation in New AIDS Cases --AIDS Healthcare Foundation: What: Florida AIDS Walk When: Sunday, April 27, 2008 Opening Ceremony: 9:15 a.m., Walk Begins: 10:00 a.m. Where:
Press Gaggle by Dana Perino and Admiral Ziemer: Business Wire - April 25, 2008; SOUTH KENT, Conn.--Aboard Air Force One En route Hartford, Connecticut 9:52 A.M. EDT MS. PERINO: Okay. We are on our way to Connecticut, and I have a special guest with me, Admiral Tim Ziemer, who I will turn over to in a second, because he heads up the President s Malaria Awareness Initiative and was with the First La
Fact Sheet: 2008 Malaria Awareness Day - President's Malaria Initiative is Spreading Hope and Saving Lives Across Africa: Business Wire - April 25, 2008; WASHINGTON--Today, President and Mrs. Bush commemorated the second annual Malaria Awareness Day and renewed America s commitment to lead the world in turning the tide against malaria in Africa and around the world. Yesterday, Mrs. Bush joined Members of Congress to announce the formation of the Congressional Malaria Ca
European Commission Approves Viread{R} for Chronic Hepatitis B: Important New Treatment Option for Millions of Europeans Affected by Life-Threatening Disease: Business Wire - April 25, 2008; FOSTER CITY, Calif.-- Gilead Sciences , Inc. (NASDAQ:GILD) today announced that the European Commission has granted marketing authorisation for Viread {R} ( tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B in all 27 member stat
Progenics and Wyeth Announce FDA Has Approved RELISTOR: First Drug for Opioid-Induced Constipation to Launch in United States: Business Wire - April 24, 2008; TARRYTOWN, N.Y. & COLLEGEVILLE, Pa.--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration ( FDA ) has approved RELISTOR™ (methylnaltrexone bromide) subcutaneous injection for the treatment of opioid-indu
Scientific Consensus on AIDS Vaccine Prospect is Bleak, Poll Reveals: "Substantial Minority" of Scientists' Polled Believe AIDS Vaccine May Never Be Developed: Business Wire - April 24, 2008; LOS ANGELES--Scientific consensus on the prospect for development of an effective preventive AIDS vaccine is bleak, according to the results of a poll of AIDS researchers and scientists which was released earlier today. The poll of AIDS scientists offered significant additional credibility to the recent public call by
Texas HIV Medication Program Awards State Pharmacy Assistance Program Contract to Ramsell Public Health Rx: Business Wire - April 24, 2008; -- Eligible AIDS/HIV Patients to Receive Assistance With Pharmaceutical Expenses OAKLAND, Calif.--Ramsell Public Health Rx today announced that the company will deliver its Pharmacy Benefit Management (PBM) solution to the Texas Department of State and Health Services (DSHS) for its new State Pharmacy Assistance Progra
Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread{R} for the Treatment of Chronic Hepatitis B: Business Wire - April 24, 2008; - Oral Presentations at EASL Following Recent CHMP Positive Opinion Support Viread as Potential New Treatment for Life-Threatening Liver Disease - EASL MILAN, Italy-- Gilead Sciences , Inc. (Nasdaq:GILD) today announced the presentation of detailed 72-week data from two pivotal Phase III clinical trials, St
Vertex Announces Positive Interim Results with Telaprevir-based Therapy in Genotype 1 Chronic Hepatitis C Patients who Failed to Achieve SVR with Previous Pegylated Interferon & Ribavirin Treatment: Business Wire - April 24, 2008; -Interim results to be presented in late-breaker poster presentation at EASL on April 24- -Significant early on-treatment viral response from patients who previously failed therapy- MILAN, Italy--In a late-breaker poster presentation at the 43rd Annual Meeting of the European Association for the Study of the Liver (EAS
Global AIDS Alliance Welcomes Call for Foreign Aid Overhaul: Business Wire - April 23, 2008; WASHINGTON--Today, the US Congress began a long overdue overhaul of the US foreign assistance process, which experts are saying is urgent if the US is to get good value-for-money in foreign aid. In the House of Representatives, the Foreign Affairs Committee heard from top experts who called for a Cabinet-Level Departme
New Zealand Delivers Personalized and Affordable, High Quality Medical Care for North American 'Medical Tourists': Business Wire - April 23, 2008; UCKLAND, New Zealand--New Zealand emerges as one of the most affordable options for Americans and Canadians seeking medical care and treatment in a first world environment where English is the primary language, reports Medtral New Zealand, a health care organization based in New Zealand (www.medtral.com) which coordina
Guardian Announces Release of Letter to Shareholders to Update Investors on Latest Strategic Achievements: Business Wire - April 23, 2008; -- CEO Spotlights Company s Transformation from Development Stage to Commercialization of Next Generation Threat Detection Imaging Technology HERNDON, Va.--Guardian Technologies International, Inc. (OTCBB:GDTI), innovators of groundbreaking threat detection technology with critical and immediate applications for the ho
Aethlon Medical to Pursue U.S. Government Biodefense Contract: Business Wire - April 23, 2008; SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it will submit a contract response to a BROAD AGENCY ANNOUNCEMENT (BAA) solicitation entitled Application of Platform Technologies for the Development of Therapeutic Agents for Biodefense . This solicitation (DMID-NIAID-NIHAI20080022BARDA) represents a
Argos Therapeutics Secures $35.2 Million Series C Financing: Funding to Advance Arcelis{TM} Personalized Immunotherapy Programs in HIV and Cancer, and Novel Immunosuppressant, CD83: Business Wire - April 23, 2008; DURHAM, N.C.--Argos Therapeutics today announced the closing of a $35.2 million tranched Series C financing. The financing was led by TVM Capital and included participation from new investors Mizuho Capital, Morningside Group and Japan Asia Investment Co. Existing Argos investors Lumira Capital, Forbion Capital Partner
Telaprevir-Based PROVE Studies Show Significantly Higher SVR Rates in Treatment-Naive Genotype 1 Hepatitis C Patients in Half the Time of Current Treatments: Business Wire - April 23, 2008; - High sustained virologic response (SVR) rates of 61% in PROVE 1 and 68% in PROVE 2 with 24-week telaprevir-based treatment regimen - - Telaprevir first and only investigational HCV protease inhibitor in Phase 3, ADVANCE trial underway - MILAN, Italy--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced
PuriCore to Present Clinical Case Findings for Vashe{R} Wound Therapy at SAWC: Three Conference Posters Plus Lecture Sessions on Hypochlorous Acid Solutions in Wound Management: Business Wire - April 23, 2008; MALVERN, Pa. & STAFFORD, England--PuriCore (LSE:PURI), the life sciences company focused on the control of infectious pathogens with its patented, safe, and natural antimicrobial technology, will feature its latest developments and clinical results for its proprietary Vashe Wound Therapy Solution at the Symposium o
MEDIVIR, INTERIM REPORT, 1 January - 31 March 2008: Business Wire - April 23, 2008; STOCKHOLM, Sweden--Regulatory News: * Consolidated net sales were SEK 4.2 (53.3) m. * The loss after tax amounted to SEK -41.2 (-25.6) m. * Earnings per share amounted to SEK -1.98 (-1.52) m. * Cash flow from operating activities increased by SEK 29.1 m to SEK -5.5 (-34.6) m. Liquid assets amounted to SEK 323.5 (369.8)
Cytheris Announces New Phase I Study of Interleukin-7 As Immunotherapy In Treatment of Bone Marrow or Peripheral Blood Stem Cell Transplant Patients: Business Wire - April 23, 2008; -- Clinical Trial is Designed to Investigate Use of IL-7 in Treatment of Immunodeficient Transplant Recipients Who Are Vulnerable to a Variety of Bacterial, Viral, and Fungal Infections PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulat
Zacks Analyst Interview Highlights: Health Net, Humana and Allion Healthcare.: Business Wire - April 21, 2008; CHICAGO--Zacks.com releases the latest Analyst Interview. Today s interview is with senior analyst Chris Kallos, who discusses Health Net (NYSE: HNT), Humana (NYSE: HUM) and Allion Healthcare (Nasdaq: ALLI). A synopsis of today s Analyst Interview is presented below. The full article can be read at http://at.zacks.com/
POC Testing for Infectious Diseases Gains Traction in the European Molecular POC Testing Markets: Business Wire - April 21, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c89284) has announced the addition of The Emerging European Molecular POC Testing Markets to their offering. Point of care (POC) diagnostics market has experienced great success due to its benefits of advanced technology, quick turnaround
BioAlliance Pharma Announces Preliminary Results from the Pivotal US Phase III Trial for Loramyc{TM}: Business Wire - April 21, 2008; PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections, in cancer and HIV, today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc{TM} (miconazole Lauriad{R}), Mucoadhesive Buccal
Merck Reports First-Quarter 2008 Financial Results: Business Wire - April 21, 2008; * Company Announces First-Quarter 2008 Non-GAAP EPS of $0.89, Excluding Certain Items; First-Quarter GAAP EPS of $1.52 * Key Products Including SINGULAIR, COZAAR/HYZAAR and VARIVAX Generate Solid Year-Over-Year Revenue Growth * JANUVIA, JANUMET, GARDASIL and ISENTRESS Launches Continue Internationally * Merck Records $
Avexa Appoints US-Based Non-Executive Director: Business Wire - April 18, 2008; MELBOURNE, Australia--Avexa Ltd (AVX) announced today that it has appointed Nathan Drona a Non-Executive Director of the Company. Nathan Drona is an experienced international investment banker in the life sciences industry and has successfully advised numerous companies in the US, Europe, and Australia in mergers and a
NIH's National Library of Medicine Opens Exciting New Interactive Exhibition, "Against the Odds: Making a Difference in Global Health": Business Wire - April 17, 2008; BETHESDA, Md.--National Library of Medicine, the world s largest medical library and a component of the National Institutes of Health (NIH), today opened a new interactive exhibition, Against the Odds: Making a Difference in Global Health on the NIH campus in Bethesda, Md. Against the Odds presents a look at the public
Remarks by President Bush and Prime Minister Gordon Brown of the United Kingdom in Joint Press Availability: Business Wire - April 17, 2008; WASHINGTON--Rose Garden 2:43 P.M. EDT PRESIDENT BUSH: Thank you all. Mr. Prime Minister, welcome to the Rose Garden. Glad you re here. It s a beautiful day. I m -- been a pleasure to welcome a good friend to the Oval Office, and had a good discussion. Appreciate our special relationship with Britain, and I believe that
Flowers Heritage Foundation to Give Away One Million Condoms: Fight Against AIDS Begins With One Condom at a Time to San Francisco Bay Area and International Healthcare Organizations: Business Wire - April 17, 2008; OAKLAND, Calif.--The Flowers Heritage Foundation today announced the giveaway of one million condoms to San Francisco Bay Area and international healthcare organizations to help in the fight against AIDS. A 2006 California Department of Health Services report states there are 142,513 adults living with AIDS in Californ
OraSure Technologies to Defend Patent Infringement Lawsuit: Business Wire - April 17, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) announced that it has received a complaint from Inverness Medical Innovations, Inc. (AMEX:IMA), Inverness Medical Switzerland GmbH and Church & Dwight, Co., Inc. (NYSE:CHD), filed in the United States District Court for the District of New Jersey, allegin
Calypte’s Aware™ HIV-1/2 OMT Approved as China's Only Rapid Oral HIV Test: Business Wire - April 17, 2008; --Approval Enables Manufacturing, Marketing, Distribution and Sales throughout China Company to Hold Conference Call at 10:30 a.m. EDT Today to Discuss Developments PORTLAND, Ore--Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that its Chines
Gilead Sciences Announces First Quarter 2008 Financial Results: Business Wire - April 16, 2008; - Record Total Revenues of $1.26 Billion, Up 22 Percent over First Quarter 2007 - - Record Product Sales of $1.14 Billion, Up 36 Percent over First Quarter 2007 - - First Quarter EPS of $0.51 per Share - - First Quarter Non-GAAP EPS of $0.54 per Share, Excluding Stock-based Compensation Expense - FOSTER CITY, Calif.--(
Trimeris Reports First Quarter 2008 FUZEON{R} Sales Results: Business Wire - April 16, 2008; MORRISVILLE, N.C.--Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the first quarter of 2008 were $42.7 million, down 34 percent from $64.3 million in the first quarter of 2007. Net sales of FUZEON in the U.S. and Canada for the first quarter of 2008 were $17.0 million, down 42 percent f
Calypte Biomedical Corporation to Host Conference Call on April 17, 2008 to Discuss Significant International Development: Business Wire - April 16, 2008; PORTLAND, Ore.--Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that it will hold a conference call for the investment community on Thursday, April 17, 2008 at 10:30 a.m. EDT to discuss a significant international development. The call can be
Whatman works with Clinton Foundation on HIV/AIDS Initiative: Business Wire - April 16, 2008; FLORHAM PARK, N.J.--Whatman, the global leader in separations technology, announces a donation of Neonatal Screening Cards to the Clinton HIV/AIDS Initiative (CHAI). The Whatman 903 Neonatal Cards were donated to CHAI for the collection of blood samples for early HIV/AIDS detection in infants in connection with CHAI s
Press Briefing by Dana Perino: Business Wire - April 15, 2008; WASHINGTON--James S. Brady Press Briefing Room 12:32 P.M. EDT MS. PERINO: Let me start off just with a couple of comments about the President welcoming Pope Benedict XVI to America today. Tomorrow in his remarks, the President will say to the Holy Father that millions of Americans have been praying for his visit. He wi
GenVec Presents New Research on TNFerade{TM}: Business Wire - April 15, 2008; GAITHERSBURG, Md.--At today s 98th Annual Meeting of the American Association of Cancer Research (AACR) in San Diego, GenVec, Inc. (Nasdaq:GNVC) presented preclinical data illustrating the activity of GenVec s lead product candidate, TNFerade{TM}, when used in combination with gemcitabine in preclinical models of pancr
HIV Incidence Rises in Minnesota: Minnesota AIDS Project Emphasizes Need for Prevention Education: Business Wire - April 15, 2008; MINNEAPOLIS--According to statistics released today by the Minnesota Department of Health, 325 new cases of HIV were reported in Minnesota during 2007. The Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, noted specific areas of concern including: * A total of 325 new cases of H
Inhibitex Presents Encouraging Phase I Data on FV-100 At 21st International Conference on Antiviral Research: Business Wire - April 15, 2008; ATLANTA--Inhibitex, Inc. (Nasdaq: INHX), a biopharmaceutical company focused on the development of products to treat and prevent serious infectious diseases, announced that it is presenting data from a Phase I clinical study of FV-100, a highly potent antiviral compound in development for the treatment of shingles, at
National Experts Retreat from Estimate of 40,000 New US HIV Infections Annually: Still No Date Given for Release of Crucial Data Expected to Show Far Higher Incidence; AHF to Press White House for CDC's Release of New HIV Numbers: Business Wire - April 15, 2008; WASHINGTON--In a community forum and conference call hosted today by the Federal AIDS Policy Partnership (FAPP) to discuss HIV incidence versus actual reported cases of HIV in the US and the long-awaited release of new, more closely-studied HIV data from 2005, HIV/AIDS experts participating in the call appeared to retr
AHF Supports Obama's Call for More AIDS Drugs for Poor Patients: Call Comes as Senate Considers PEPFAR Global AIDS Bill with No Treatment Funding Requirement: Business Wire - April 14, 2008; WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS medical care to more than 65,000 individuals in 20 countries worldwide, today supported Senator Barak Obama s call for more widespread availability of AIDS drugs for poor patients, a call he made Sunday evening during CNN s Compassion Forum, a televised
Internet Sexuality Information Services (ISIS) Exposes Ideas for Preventing HIV and other STDs with an Underwear Design Contest: Brickfish User-Generated Content Campaign Lets Consumers Spread the Word, not Disease: Business Wire - April 14, 2008; SAN DIEGO--Brickfish{TM}, a social media advertising platform and Internet Sexuality Information Services, Inc. (ISIS), a not-for-profit organization dedicated to promoting sexual health, are inviting people to design intimate apparel to help get the word out about preventing HIV and other sexually transmitted diseases
Nutra Pharma Acquires Remaining Interest in Biopharmaceutical Drug Discovery Company - ReceptoPharm, Inc.: Business Wire - April 14, 2008; BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced that on April 10, 2008, it had acquired the remaining outstanding equity in its drug discovery holding, ReceptoPharm, Inc. ( Receptopharm ). We are extremely pleased to have
To The Top! SanDisk Supplies Flash Memory for High-Tech Climbing Attempt of Mt. Everest: Three-Member Team Hopes to Reach Summit in May; Objective is Raising Awareness of AIDS Pandemic in Africa: Business Wire - April 14, 2008; MILPITAS, Calif.--Equipped with portable electronic devices that range from high-definition camcorders to satellite-based mobile phones, a three-member climbing team sponsored by Dell (PRODUCT) RED + Windows Vista (PRODUCT) RED, MSN and MSNBC - and carrying a variety of flash-memory products from SanDisk Corporation (N
Actor Blair Underwood to Join Thousands of Walkers for Florida: Funds Raised Will Support Expanded HIV Testing and Statewide Medical Care: Business Wire - April 14, 2008; -- 87,000 Floridians Are Infected with HIV/AIDS, South Florida Leads the Nation in New AIDS Cases FT. LAUDERDALE, Fla.--AIDS Healthcare Foundation: What: Florida AIDS Walk When: Sunday, April 27, 2008 Opening Ceremony: 9:15 a.m., Walk Begins: 10:00 a.m. Where: Huizenga Plaza, Downtown Ft. Lauderdale Who: Blair Unde
Market for POC Molecular Tests Boosted by Discovery of New Disease Markers: Business Wire - April 14, 2008; LONDON--As developers of point of care (POC) molecular tests enhance their application scope to detect new disease markers, the POC molecular diagnostics market will present attractive opportunities. Market participants can enhance the utilization of POC molecular tests by improvising the existing tests and simultaneou
Walgreens Specialty Pharmacy Launches New HIV/AIDS Web Site: Patients and Caregivers Provided with Information and Advice from HIV-Trained Pharmacists: Business Wire - April 10, 2008; DEERFIELD, Ill.--Walgreens (NYSE:WAG)(NASDAQ:WAG) announced today that Walgreens Specialty Pharmacy has launched a new HIV-focused Web site, HIV.Walgreens.com, to expand the availability of HIV/AIDS information to patients and caregivers. The new site complements Walgreens Specialty Pharmacy s current HIV/AIDS patient
AHF's African Doctors and Treatment Clients Lobby Senate for Proposed Legislation Lacks Treatment Funding Requirement, Key to PEPFAR's Success to Date: Business Wire - April 9, 2008; WASHINGTON--Six AIDS medical care providers and treatment clients from Uganda and South Africa are visiting Washington, DC this week for a series of meetings on Capitol Hill with Senate and Congressional leaders to lobby Congress as they consider bills to reauthorize PEPFAR (the President s Emergency Plan for AIDS Reli
Nagasaki University Awarded Clinical Research Grant to Study Cell-Enhanced Reconstruction in HIV Therapy-Induced Facial Atrophy Using Celution{R} 800 System: Business Wire - April 9, 2008; SAN DIEGO & NAGASAKI, Japan--Nagasaki University will sponsor and perform a clinical study on the use of cell-enhanced reconstruction in HIV therapy-induced facial atrophy, a condition where adipose (fat) tissue becomes unevenly lost, leaving patients with a gaunt appearance. The study will be funded through a thre
Therapeutic Vaccine Company Inovio Biomedical Demonstrates Utility of Its Electroporation Delivery Technology as Potent Vaccine Adjuvant: Published in Journal of Virology, Study Shows DNA Vaccine Delivered Via Electroporation Induces Recruitment of Immune Cells to the Site of Administration: Business Wire - April 9, 2008; -- Study Led by Principal Investigator Dan H. Barouch, MD, PhD, a Scientist in the Division of Viral Pathogenesis at BIDMC and Associate Professor of Medicine at Harvard Medical School SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electr
Radiant Development Announces New Chief Medical Officer: Business Wire - April 9, 2008; CHICAGO--Radiant Development is pleased to announce the addition of Joan L. Drucker, MD, as Chief Medical Officer. Dr. Drucker will provide medical consultation, regulatory and pharmacovigilance expertise as well as oversight for clinical studies managed by Radiant Development. Dr. Drucker possesses clinical, managemen
How To Get Ahead With Pharmacogenomics Highlights How Companies Must Adopt Technologies That Will Enable Them To Develop Better Drugs: Business Wire - April 8, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c88085) has announced the addition of new Decision Resources report How to Get Ahead with Pharmacogenomics to their offering. Introduction Pharmacogenomics (PGx) is an evolutionary-not a revolutionary-process. The blockbuster business mode
Ben & Jerry's Launches Partnership with the ONE Campaign to Bring New Voices to the Fight against Global Poverty: Ice Cream Maker's ONE Cheesecake Brownie to help raise awareness: Business Wire - April 8, 2008; BURLINGTON, Vt.--Dedicated to making poverty history, the ONE Campaign welcomed Ben & Jerry s as a partner, announcing a joint endeavor today to fight extreme poverty and preventable disease around the world. The partnership was announced at the Ben & Jerry s Scoop Shop in Burbank, California, and featured Ben
Allion Healthcare Announces Closing of Biomed Acquisition: * Expands market opportunity to include patients with immune deficiencies, hemophilia and other chronic conditions: Business Wire - April 7, 2008; -- Diversifies payor base by increasing revenue from non-governmental payors --Acquisition anticipated to be accretive to earnings MELVILLE, N.Y.--Allion Healthcare (Nasdaq: ALLI) today announced that it has been granted early termination of the waiting period required by the Hart-Scott-Rodino Act and has closed its ac
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Canaccord|Adams Hepatitis C Conference: Business Wire - April 7, 2008; CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the Canaccord|Adams Hepatitis C Conference on Wednesday, April 9, 2008 at 4:00 p.m. EDT. The presentation will be webcast live and may be accessed from Events & Presentations on th
Alicia Keys' Documentary "Alicia in Africa: Journey to the Motherland" Available for Exclusive Download on SpiralFrog{TM}: Business Wire - April 7, 2008; NEW YORK--SpiralFrog, Inc., (www.spiralfrog.com) the free and legal, ad-supported web-based music service, today announced it was selected by the non-profit organization, Keep a Child Alive (KCA), to be the exclusive download partner for Alicia in Africa: Journey to the Motherland, the documentary of Grammy Award-winni
NanoViricides Commences HIV Drug Animal Trials: Goal is to identify best candidates and optimal dosages for later studies at a major US facility: Business Wire - April 7, 2008; WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), said that preliminary animal trials of the Company s HIV therapeutic candidates have begun at a BioSafety Level 3 (BSL-3) Laboratory facility in Boston, MA. The initial results are expected before the end of next month. These animal studies will be conducted by
Modest Global AIDS Funding Increase Approved by House: Business Wire - April 4, 2008; WASHINGTON--A modest, 27% increase in global HIV/AIDS spending was authorized this week in an important vote in the House of Representatives. We welcome this reauthorization of the AIDS program and congratulate members for avoiding a partisan logjam on this crucial issue, said Dr. Paul Zeitz, Executive Director of the
PerkinElmer Announces New Innovations to Strengthen Drug Discovery Product Portfolio: Latest AlphaLISA{TM} Immunoassay Kits Reduce Customers' Time, Labor and Materials; Enhance Research Efforts for Cancer, Alzheimer's, Diabetes, HIV, Inflammation and Cardiovascular Disease: Business Wire - April 4, 2008; ST. LOUIS--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the release of eight new AlphaLISA{TM} immunoassay kits in conjunction with the Society for Biomolecular Sciences (SBS) 14th Annual Conference and Exhibition. These latest innovations include research reagents an
Skyscape Brings Johns Hopkins POC-IT Guides to Mobile Network: Popular ABX and HIV Guides, Continuing Medical Education Now Available on Mobile Platforms including Smart Phones: Business Wire - April 3, 2008; MARLBORO, Mass.--Skyscape{R}, the worldwide leading service for trusted medical information by specialty for mobile devices announced today that it is the exclusive mobile service provider of the popular Antibiotic (ABX) and HIV Guides. Developed by the Johns Hopkins POC-IT (Point of Care Information Technology) Center
Statement by the Press Secretary: Business Wire - April 2, 2008; BUCHAREST, Romania--THE WHITE HOUSE Office of the Press Secretary Today the House of Representatives approved the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act. This strong bipartisan vote advances the reauthorization of the life-saving work of the P
House PEPFAR AIDS Bill an "Historic Retreat" on Treatment, Says AHF: Proposed Legislation Lacks Treatment Funding Requirement, Key to PEPFAR's Success to Date: Business Wire - April 2, 2008; WASHINGTON--AIDS Healthcare Foundation (AHF) (www.aidshealth.org), which provides AIDS medical care to more than 65,000 individuals in 20 countries worldwide, expressed its profound disappointment with the House of Representatives for its passage today of the bill to reauthorize PEPFAR (the President s Emergency Plan f
Press Gaggle by Dana Perino: Business Wire - April 1, 2008; BUCHAREST, Romania--Aboard Air Force One En route Bucharest, Romania 5:43 P.M. (Local) MS. PERINO: Let me start off by saying that we re going to Bucharest, Romania, which is always helpful to tell you where we re going. Q The President got his daily intelligence briefing. That s always good. MS. PERINO: We don t have
Remarks by President Bush After Viewing HIV/AIDS Skit: Business Wire - April 1, 2008; KIYV, Ukraine--School 57 3:56 P.M. (Local) PRESIDENT BUSH: Thank you all very much for letting Laura and me come by your school. And thank you all for coming. You did an excellent job. And we love the Peace Corps. They re great, aren t they? Listen, Laura and I are very impressed by your country. It s exciting to be in
2008 BIO International Convention Focuses on Global Reach of Biotechnology: Wednesday, June 18th Designated as BIO International Day 2008 BIO International Convention: Business Wire - April 1, 2008; WASHINGTON--The 2008 BIO International Convention will demonstrate the biotechnology industry s global focus with international case studies, global health breakout sessions and receptions that spotlight examples of biotechnology innovation from around the world. The BIO International Convention, hosted by the Biotechn
PURE Bioscience Announces Launch of Earth Friendly Chemicals' QuikCharge{R} SDC: New "Powered by SDC{TM}" Disinfectant Launched at Pumper & Cleaner Environmental Expo: Business Wire - April 1, 2008; SAN DIEGO--PURE Bioscience (OTCBB: PURE) today announced the launch of QuikCharge{R} SDC by Earth Friendly Chemicals. The latest private label brand of PURE s patented silver dihydrogen citrate (SDC)-based disinfectant was introduced at the 2008 Pumper & Cleaner Environmental Expo, the world s biggest annual trade
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval: First-in-world approval of drug to treat opioid induced constipation: Business Wire - April 1, 2008; COLLEGEVILLE, Pa. & TARRYTOWN, N.Y.--Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that Wyeth has received marketing approval from Health Canada , the Canadian Regulatory Agency, for RELISTOR{TM} (methylnaltrexone bromide injection) for s
Argos Therapeutics Presents Positive Phase 1 Safety Data for its Arcelis{tm} Platform in HIV at Keystone Symposia-Additional Presentation on Methods to Improve Antigen Expression in Immunotherapies-: Business Wire - March 31, 2008; DURHAM, N.C.--Argos Therapeutics today announced the presentation of positive safety and feasibility data from a Phase 1 clinical trial of AGS-004 in HIV-infected adults in combination with antiretroviral therapy (ART). AGS-004 is an adaptation of the Company s Arcelis{tm} technology, a personalized, RNA-loaded dendrit
Merck/Schering-Plough Pharmaceuticals Comments on Results of the ENHANCE Study: Study Presented at American College of Cardiology Scientific Sessions and Published in On-Line Version of The New England Journal of Medicine: Business Wire - March 30, 2008; CHICAGO--Results of ENHANCE (Ezetimibe aNd simvastatin in Hypercholesterolemia enhANces atherosClerosis rEgression), an imaging trial in 720 patients with heterozygous familial hypercholesterolemia (HeFH), a rare genetic condition that causes very high levels of LDL bad cholesterol and greatly increases the risk for pr
Statement by Robert Janssen, M.D. -- Centers for Disease Control; Director, Division of HIV/AIDS Prevention; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Centers for Disease Control and Prevention and Prevention: Business Wire - March 28, 2008; ATLANTA -- In response to statements today by the AIDS Healthcare Foundation, CDC provides the following important clarification and corrections regarding CDC s 2006 HIV/AIDS Surveillance Report, published on March 26, 2008. (http://www.cdc.gov/hiv/topics/surveillance/resources/reports/ 2006report/pdf/2006SurveillanceR
AHF: CDC Makes It Official--HIV Infections Up 48% Nationwide: Business Wire - March 27, 2008; AHF Calls Numbers a National Catastrophe; Notes Lifetime Costs of Treatment Will Approach $36 Billion LOS ANGELES -- AIDS Healthcare Foundation (AHF) (www.aidshealth.org) will host a press teleconference Friday March 28th at 11:00 AM Eastern Daylight Time to respond to the release of a long-awaited report by the Center
Kimberley Locke Auctions Her Christian Siriano "Goddess Couture" Dress at clothesoffourback.org: Business Wire - March 27, 2008; LOS ANGELES--Wearing a Christian Siriano designed couture dress, Kimberley Locke performed her new hit single Fall live on AMERICAN IDOL Wednesday, March 26 on FOX. The one-of-a-kind Siriano creation is available for auction at www.clothesoffourback.org. Funds raised through the Kimberley Locke/Christian Siriano dress
NanoViricides to Begin HIV Animal Trials: Harnessing New Therapeutic Opportunities as Vaccine Trial Failures Mount: Business Wire - March 27, 2008; WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), announced today that preliminary animal trials of HivCide-I{TM}, the Company s proposed HIV therapeutic, will begin soon at a BSL-3 facility in Boston, MA. The initial results are expected by the second week of May. These animal studies will be conducted by Dr.
Cost-Effective Combination Vaccines Offer Tremendous Growth Potential in the South African Paediatric Vaccines Markets: Business Wire - March 27, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c86823) has announced the addition of Strategic Analysis of the South African Paediatric Vaccines Markets to their offering. This Frost & Sullivan research service titled Strategic Analysis of the South African Paediatric Vaccines Mark
'Islands of the World Fashion Week' (IWFW) to Debut in Nassau, The Bahamas, November 5-8, 2008: IWFW to Draw Attention to Several Global Issues Which Significantly Affect Island States - Including the Environment and Environmental Change, the Education of Youth on HIV/AIDS, and Poverty Alleviation: Business Wire - March 25, 2008; NASSAU, The Bahamas--The fashion world is buzzing about Islands of the World Fashion Week (IWFW) to take place in Nassau, The Bahamas, November 5-8, 2008, set to showcase well-known and new designers from islands around the world and to promote cultural diversity and creativity. The producer of IWFW is Mode Iles, Ltd.,
Avexa Chairman Retires: Business Wire - March 25, 2008; MELBOURNE, Australia--Avexa Ltd (AVX) announced today that its Chairman, Dr Hugh Niall, has retired from the Board of the Company effective immediately. Non-Executive Director Mr. Stephen Cooper will assume the role of Chairman pending a search for a new Board member to assume the role of Chairman on a longer term basi
Ceragenix Enters into Agreement to License CSA-54 and other Ceragenin Compounds To Biopharmaceutical Company for HIV and STD Applications: FirstPoint Biotech To Pay Development Costs; Ceragenix To Receive Milestone Payments and Royalties: Business Wire - March 25, 2008; DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the Company ), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it has entered into a license agreement with FirstPoint Biotech, Inc. ( FPBT ) (www.firstpointbiotech.com), a privately held biopharmace
Teleconference: AHF to Call for Halt to HIV Vaccine Funding: Business Wire - March 25, 2008; WASHINGTON--In conjunction with today s HIV Vaccine Summit in Bethesda, Maryland, AIDS Healthcare Foundation (AHF) will host a press teleconference on Tuesday, March 25th at 12:15 P.M. (EDT) to call for the suspension of costly HIV vaccine research funding and the re-allocation of resources into effective HIV/AIDS prev
City of West Hollywood to Sponsor the "Gay Men's Forum: The Body and Soul of the Community" on Saturday, April 19, 2008 at Plummer Park: Business Wire - March 24, 2008; WEST HOLLYWOOD, Calif.--The City of West Hollywood will host the Gay Men s Forum: The Body and Soul of the Community on Saturday, April 19, 2008 from 9 a.m. to 5 p.m. in Fiesta Hall at Plummer Park, 7377 Santa Monica Boulevard, West Hollywood. This day-long event will focus on the theme: Where We ve Been. Where We Are.
Dr. Howard Fields to Join NanoViricides as Vice-President of Virology: International Hepatitis Expert from CDC to Manage R&D and Collaborations: Business Wire - March 24, 2008; WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), announced today that Howard Fields, PhD, currently a member of the Scientific Advisory Board, will join the Company as Vice President of Virology. We re very pleased to have Dr. Fields, a scientist of great international repute, joining us. He wil
The Zimbabwe Pharmaceuticals and Healthcare Report Provides Independent Forecasts and Competitive Intelligence on Zimbabwe's Pharmaceuticals and Healthcare Industry: Business Wire - March 20, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c86494) has announced the addition of Zimbabwe Pharmaceuticals and Healthcare Report Q1 2008 to their offering. The struggling Zimbabwean economy, hyperinflation and the isolationist and internationally unacceptable government policy will
European CHMP Issues Positive Opinion for Viread{R} for the Treatment of Chronic Hepatitis B: Milestone in the Development of Potential New Treatment for Life-Threatening Disease: Business Wire - March 19, 2008; FOSTER CITY, Calif.-- Gilead Sciences , Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion on the company s application to extend the indication for Viread
Supplemental Application for GARDASIL, Merck's Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45: Business Wire - March 19, 2008; WHITEHOUSE STATION, N.J.-- Merck & Co. , Inc. announced today that the U.S. Food and Drug Administration ( FDA ) has accepted, and designated for priority review, the supplemental Biologics License Application (sBLA) for GARDASIL[registered trademark] [Human Papillomavirus Quadrivalent] (Types 6, 11, 16, 18) Vaccin
M·A·C AIDS Fund Finding and Funding "Answers" to UK AIDS Epidemic: Business Wire - March 19, 2008; Grant-Maker Calls for Applications to Address Stigma, Shame Surrounding AIDS in UK During London Expert Roundtable; [pounds]250,000 in Grants Available LONDON--The MAC AIDS Fund, the philanthropic arm of Estee Lauder-owned M·A·C Cosmetics, gathered a group of AIDS thought-leaders in London today for a discussion to pro
American Academy of HIV Medicine Streamlines Delivery of Critical News and Information to Its Members and HIV Specialists Through ActiveAccess Desktop Application: Web 2.0 Technology Helps Organization Communicate Efficiently and Quickly Without Relying on Email or the Web: Business Wire - March 18, 2008; CHANTILLY, Va.--BIA Information Network (BIN) (http://www.activeaccess.com), a leading provider of private-label desktop applications, announced today that the American Academy of HIV Medicine (AAHIVM), an independent organization of HIV care providers dedicated to promoting excellence in HIV/AIDS care, will launch AAH
OC AIDS Walk Returns to Angel Stadium of Anaheim: Business Wire - March 17, 2008; IRVINE, Calif.--The bases will be loaded as over 8,000 participants step up to the plate on Saturday, May 10th for the 22nd Annual OC AIDS Walk at Angel Stadium of Anaheim. The Walk expects to raise a Grand Slam $750,000. As registration begins at 7am, wake up as NBC4 Today In L.A. s Robert Kovacik and Legendary KLOS D
ABC News Reports on the Aethlon Hemopurifier{TM}: Business Wire - March 17, 2008; SAN DIEGO)--Aethlon Medical, Inc., (OTCBB:AEMD) a pioneer in developing therapeutic devices for infectious disease, disclosed today that its Hemopurifier{tm} treatment technology is the subject of an ABC news story. The story can be accessed online at: www.wjla.com/news/stories/0308/503883.html About Aethlon Medical
OraSure Technologies to Present at the Cowen & Co. Health Care Conference: Business Wire - March 17, 2008; BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Ronald H. Spair, Chief Operating Officer and Chief Financial Officer, will speak to the investment community at the Cowen & Co. Health Care Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Intern
Webcast Alert: Lippert/Heilshorn Life Sciences Virtual Conference (Chembio Diagnostics, Inc.): Business Wire - March 17, 2008; NEW YORK--Chembio Diagnostics, Inc. (OTCBB:CEMI) announces the following Webcast: What: Lippert/Heilshorn Life Sciences Virtual Conference When: March 18, 2008 @ 10:00 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=127008 How: Live over the Internet -- Simply log on to the web at the address above.
Boston's Best Restaurants Host the 16th LifeSavor “Best Dinner Party with a Conscience”: Business Wire - March 17, 2008; BOSTON--Greater Boston s culinary community and local dignitaries will join together to host the 16th annual LifeSavor, a celebratory fundraiser, on Thursday, March 27th, at Langham Hotel Boston in downtown Boston. Sponsored by State Street Corporation, MAC VIVA GLAM, and The Langham Hotel Boston, this year s LifeSavor
Incyte to Provide Update on Clinical Programs at Cowen Health Care Conference: A live and archived copy of the presentation will be available on Incyte's website on March 17, 2008, at 3:15 pm ET: Business Wire - March 17, 2008; WILMINGTON, Del.--Incyte Corporation (Nasdaq:INCY) will announce today at the Cowen and Company 28th Annual Health Care Conference results from its initial meeting with the U.S. Food & Drug Administration ( FDA ) regarding the development of its lead JAK inhibitor, INCB18424, for myelofibrosis. Paul Friedman, M
Progenics Pharmaceuticals Reports Fourth Quarter and Year End Results: Business Wire - March 17, 2008; TARRYTOWN, N.Y.--Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced its results of operations for the fourth quarter and year ended December 31, 2007. Revenues for the fourth quarter ended December 31, 2007 totaled $15.5 million compared to $21.9 million for the same quarter in 2006. For the year ended Dece
Drug Patent Decision "A Victory for the Thai People," says AIDS Healthcare Foundation: Business Wire - March 14, 2008; WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 65,000 individuals in 20 countries worldwide, today joined other global health advocates in praising the announcement by Thailand s new Minister of Health Chaiya Sasomsap that the country will continue to override
Statement by the First Lady During a Visit With HIV-Positive Youth: Business Wire - March 13, 2008; PORT-AU-PRINCE, Haiti--GHESKIO HIV/AIDS Center Port-au-Prince, Haiti March 13, 2008 11:25 A.M. (Local) MRS. BUSH: And for the press, adolescents with AIDS or are HIV positive are particularly difficult because it s hard to follow them to make sure they continue to come back as they re taking ARVs. And so I want to than
Statement by the First Lady During a Briefing at GHESKIO: Business Wire - March 13, 2008; PORT-AU-PRINCE, Haiti--GHESKIO HIV/AIDS Center Port-au-Prince, Haiti March 13, 2008 10:55 A.M. (Local) MRS. BUSH: Well, one of the things I hope the American press hears from this -- the press from the United States that are here -- is that Haiti is a PEPFAR country, one of the targeted countries with PEPFAR funds. I t
Statement by the First Lady after a Visit: Business Wire - March 13, 2008; PORT-AU-PRINCE, Haiti--GHESKIO HIV/AIDS Center Port-au-Prince, Haiti March 13, 2008 11:35 A.M. (Local) MRS. BUSH: We ve just been talking with women who, some of them, are HIV positive and have gone on antiretrovirals, and they start to feel good. And so they re ready to work and support their families. So they have go
Minnesota AIDS Project to Lead AIDS Action Day at the State Capitol on March 18, 2008: Business Wire - March 13, 2008; MINNEAPOLIS--Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, will bring together Minnesotans from all walks of life seeking to convey their concerns about HIV prevention and policy to their legislators on March 18. Attendees will meet with their elected representatives and rall
Biden-Lugar AIDS Legislation Passed by Senate Committee: Senator Lugar Calls $50 Billion a "Reasonable Target": Business Wire - March 13, 2008; WASHINGTON--Global AIDS Alliance today released the following statement: Today, by an overwhelming majority, the Senate Foreign Relations Committee approved legislation that promises a major funding increase for AIDS, tuberculosis and malaria programs. The bill would authorize, though not appropriate, a total of $50 bi
African Delegation of Health Officials Visit Washington to Discuss the Importance of the PEPFAR Program in Combating AIDS, Malaria, and TB: Group co-convened by The AIDS Institute and The Whitaker Group: Business Wire - March 13, 2008; WASHINGTON--This past week a delegation of 15 leading African health officials representing Ghana , Uganda , Tanzania , Kenya , Rwanda , Ethiopia , Zambia ,
Significant Donor Funds Continue to Pour into Africa's Healthcare Projects: Business Wire - March 13, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c85751) has announced the addition of International Donor Funding for the Healthcare Industry in Key Sub-Saharan African Countries: Historical Data and Identified Ongoing Funding Sources to their offering. Africa, and in particular sub Sah
Flawed Global AIDS Bill Clears Key Senate Committee, Says AHF: Proposed Legislation Lacks Treatment Funding Requirement, Key to PEPFAR's Success to Date: Business Wire - March 13, 2008; WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 65,000 individuals in 20 countries worldwide, expressed its profound disappointment with elements of a proposed bill (HR 5501) to reauthorize PEPFAR (the President s Emergency Plan for AIDS Relief), the successful
International Funding Coupled with Large Target Population Promote Uptake of Infectious Disease Pharmaceuticals in Sub-Saharan Africa: Business Wire - March 12, 2007; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c85635) has announced the addition of Key Sub-Saharan African Infectious Disease Pharmaceutical Markets to their offering. This Frost & Sullivan research service titled Infectious Disease Pharmaceutical Markets in Key Sub-Saharan Afric
Although Slowing in the Short-term, New Study Expects the US Drug Market to Pick Up Towards 2012: Business Wire - March 11, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c85326) has announced the addition of United States Pharmaceuticals & Healthcare Report Q1 2008 to their offering. The United States Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on t
International Funding for African Healthcare Targets Key Problem Areas: Business Wire - March 11, 2008; CAPE TOWN, South Africa--Sizeable international funding is targeting the serious health challenges across sub-Saharan Africa. However, even as donors pledge significant amounts to AIDS, malaria and tuberculosis (TB) projects, information regarding the sources, values and destinations of the funding remain limited. New
Panacos to Present at Cowen Healthcare Conference: Business Wire - March 10, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the 28th Annual Cowen Healthcare Conference to be held from March 17-20, 2008 at The Boston Marriott Copley Place. Dr. Alan W. Dunton, Pan
Congress Retreats on AIDS Treatment Commitment, Say AHF's Global AIDS Doctors: US Congress Triples Funding, Yet Only Increases Treatment Goals by Half: Business Wire - March 10, 2008; WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 62,000 individuals in 20 countries worldwide, will host a press teleconference on Monday, March 10th, at 10:30 AM (EDT), in which AHF s global medical providers and officials will comment on pending US legislation
Remarks by the First Lady at USAID Celebration of International Women's Day: Business Wire - March 7, 2008; WASHINGTON--Ronald Reagan Building Washington, D.C. 11:39 A.M. EST MRS. BUSH: Thank you very much, Henrietta. Thank you all, thanks so much. Thank you, and I m thrilled with the Laura W. Bush award that you ll be giving to State Department employees. Thank you very much for honoring me this way. I m really thrilled wit
Patent Issued to Commonwealth Biotechnologies, Inc. for Real Time PCR Analysis of the Different Human Herpes Viruses: Business Wire - March 6, 2008; RICHMOND, Va.--CBI Services, a business unit within the Commonwealth Biotechnologies, Inc. group of companies (NASDAQ Capital Market:CBTE), has been notified that its patent Detection and Quantification of Human Herpes Viruses was issued by the United States Patent and Trademark Office on March 4, 2008 as US Patent 7,3
GenVec Announces Grant for HSV-2 Vaccine Program: Business Wire - March 6, 2008; GAITHERSBURG, Md.--GenVec, Inc. (Nasdaq:GNVC) announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health (NIH), to support the Company s efforts to develop novel adenovect
Catholic Charities in the Market for a New Home: As Need Grows, Non-Profit Must Grow to Serve Community: Business Wire - March 5, 2008; FORT WORTH, Texas--With a 130-percent increase in children and families served over the past five years and an economic forecast that promises even greater need, Catholic Charities Diocese of Fort Worth today announced plans to double its capacity to serve the working poor. The charity kicked off the public phase of Bu
Pete Sampras vs. Roger Federer; The NetJets Showdown: A Battle for Tennis History: Business Wire - March 5, 2008; Madison Square Garden, Monday, March 10, 2008 Event to Benefit The Dream Vaccines Foundation s Malaria Vaccine Initiative Inaugural Fundraising Event To Include Silent Auction NEW YORK--Dream Vaccines Foundation and Mymetics Corporation (OTCBB: MYMX), in association with the Marquis Jet Card and Men s Vogue, are proud
Panacos Announces Discovery of Bevirimat Patient Response Predictors: Completed Phase 2b Dose Escalation Study Determines Optimal Dose Range: Business Wire - March 4, 2008; WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that it has discovered factors that predict response to bevirimat, its lead HIV maturation inhibitor. In addition, it has completed a Phas
Chevron Unveils New Employee Giving and Volunteer Program: Chevron Humankind to Provide up to $20 Million to Nonprofit Organizations: Business Wire - March 4, 2008; SAN RAMON, Calif.--Chevron Corp. (NYSE:CVX) today announced a new employee giving and volunteer program that will provide up to $20 million annually for U.S. nonprofit organizations. The new program, Chevron Humankind, includes company matching for employee financial contributions, grants to nonprofits for volunteer ti
Non Profit Organizations Receive $200,000 in Honor of Kathy Ireland Worldwide's Record Sales: Business Wire - March 4, 2008; BEVERLY HILLS, Calif.--Four major charities will share a $100,000 gift that Kathy has designated to celebrate record-setting sales her market-leading lifestyle products firm, Kathy Ireland Worldwide, achieved in 2007. Kathy named the Elizabeth Taylor HIV/AIDS Foundation, Alliance for Christian Education, Safe Surfing a
Mymetics Corporation Hires the Investor Relations Group: Comprehensive Investor Relations and Media Outreach to Commence - Vaccine Technology, Institutional Investors and Roadshows Focus of Campaign: Business Wire - March 4, 2008; NYON, Switzerland--Mymetics Corporation (OTCBB: MYMX; http://www.mymetics.com), a biotechnology company focused on the development of protective mucosal antibody-based vaccines, hired the Investor Relations Group ( IRG ), a corporate communications firm based in New York City, to serve as its investor relations and fin
Massive Las Vegas Hepatitis C Scare Causes Public Health Crisis - Edward M. Bernstein & Associates Files Lawsuits: Over 40,000 Patients during Last Four Years Potentially Exposed to Hepatitis C or HIV Infection in Las Vegas: Business Wire - March 4, 2008; LAS VEGAS--Edward M. Bernstein & Associates, one of Nevada s leading Personal Injury Law Firms has been retained by former patients of the Endoscopy Center of Southern Nevada, who have in fact, tested positive for a Hepatitis C Infection in Las Vegas. The firm has filed individual lawsuits as well as a class action
UnitedHealth Group to Provide Immediate Resources for Those Needing Services Related to the Endoscopy Center of Southern Nevada: Business Wire - March 3, 2008; * Free NurseLine services available for Southern Nevada residents * No out-of-pocket costs for UnitedHealth customers requiring testing * Working with network physicians to support timely access to testing LAS VEGAS--UnitedHealth Group (NYSE: UNH) and its family of companies are working in collaboration with the Southe
South Africa's Pharmaceuticals and Healthcare Market Should reach US$5.82bn By 2012 Representing a CAGR Of 11.8% According to this Q1 2008 Report: Business Wire - March 3, 2008; DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c84627) has announced the addition of South Africa Pharmaceuticals and Healthcare Report Q1 2008 to their offering. The South Africa Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on South
Biomagnetics Diagnostics Corp. and How its Technology Will Change Diagnostics Testing Forever: Business Wire - February 29, 2008; ORANGEVALE, Calif.--Biomagnetics Diagnostics Corp. announced today a necessary review of its core technology. President Clayton Hardman felt it is important to expand on our last press release and point out the cost and practical advantage of our HTS-MTP diagnostics system. Today, the laboratory wholesale cost of a con
Three State Boards of Education Awarded HIV Prevention Grants by National Association of State Boards of Education: Business Wire - February 28, 2008; ALEXANDRIA, Va.--The National Association of State Boards of Education (NASBE) has made grants to three state boards of education to promote more effective instruction to K-12 students about HIV prevention. The $13,000 grants are being made to the North Carolina, Oregon, and Tennessee State Boards of Education. HIV rem
Pharmacy Benefit Management Institute Recognizes Innovation in Drug Benefit Industry: Business Wire - February 28, 2008; SCOTTSDALE, Ariz.--The Pharmacy Benefit Management Institute (PBMI) has awarded its 2008 Rx Benefit Innovation Awards to MemberHealth, LLC; Office of Group Benefits (OGB), State of Louisiana with Catalyst Rx, A HealthExtras Company; and the Upper Peninsula Health Plan with the Upper Peninsula Health Care Network. Membe
AHF to Congress: Keep PEPFAR Funding Priority on AIDS Treatment: House PEPFAR Reauthorization Bill Eliminates 55% Treatment Floor; Also Removes Abstinence Earmark: Business Wire - February 27, 2008; WASHINGTON--With a bipartisan voice vote earlier today, The House Foreign Affairs Committee today passed House Resolution 5501 (the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act), a bill to reauthorize the President s Emergency Plan for AIDS
Congress Moves to Correct and Expand AIDS Response: "Historic agreement on AIDS will save millions of lives, but it does not provide much needed funds for family planning," says GAA: Business Wire - February 27, 2008; WASHINGTON--As a fitting tribute to the late Committee Chairman Tom Lantos, Republicans and Democrats have crafted a bipartisan compromise to support AIDS, TB and malaria policy. The agreement will set US programs on a new five-year course. The bill was approved this morning at a House Foreign Relations Committee mark-
Tecan Platforms Improve Microarray Throughput and Research Quality in South Africa: Business Wire - February 27, 2008; DURHAM, N.C.--Researchers at the Centre for Proteomics and Genomics Research (CPGR) in Cape Town, South Africa , have established a high throughput biological research platform with a number of automated microarray processing systems from Tecan, including an HS 4800(trademark) Pro Hybridization Station with the new Qua
Press Briefing by Dana Perino: Business Wire - February 27, 2008; WASHINGTON--James S. Brady Press Briefing Room 12:43 P.M. EST MS. PERINO: Two statements for you. Today we learned that William F. Buckley has passed away and that has saddened everyone here at the White House. Mr. Buckley was a longtime friend of the Bush family. I informed the President of Mr. Buckley s death at 11:4
ViroStatics Establishes Scientific Advisory Board for HIV Development Program: Business Wire - February 27, 2008; SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl, a privately-held pharmaceutical company focused on the discovery and development of combination therapeutics in HIV/AIDS, virology, and other chronic diseases, today announced the formation of a Scientific Advisory Board (SAB). Chaired by Daniel Kuritzkes, MD, Dir
Flowers Heritage Foundation Board of Directors Appoints New Executive Director: AIDS Activist Gregory W. Edwards to Lead the Foundation's Fundraising Efforts and Education Programs: Business Wire - February 27, 2008; OAKLAND, Calif.--The Flowers Heritage Foundation (FHF) Board of Directors today announced its appointment of Gregory W. Edwards, Ed.D. to the role of Executive Director. In this position, Dr. Edwards will be responsible for fundraising efforts and furthering the foundation s education and awareness programs, including
Remarks by the President to the Leon H. Sullivan Foundation: Business Wire - February 26, 2008; WASHINGTON--Marriott Wardman Park Hotel Washington, D.C. 9:48 A.M. EST THE PRESIDENT: Thanks for coming. I appreciate the warm welcome. Last Thursday Laura and I returned from a six-day visit to Africa. It happened to be her fifth visit, and my second. Without a doubt, this was the most exciting, exhilarating, upliftin
Teleconference for Media: Christian Perspectives in the Debate on US Global AIDS Policy: Business Wire - February 25, 2008; **12:00 pm ET**, Monday February 25 --Global AIDS Alliance: WHAT: A debate is raging about the next steps the US should take in addressing the global AIDS epidemic. On Wednesday February 27 the US House of Representatives will begin formal consideration of a law that will set US policy on AIDS, TB and malaria for the n
Designer Diagnostics Begins Marketing First Ever Environmental Test Kit for the Detection of Nontuberculous Mycobacteria: Business Wire - February 25, 2008; BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today announced that its wholly-owned medical devices subsidiary, Designer Diagnostics, has started marketing the first-ever environmental test kit for the detection of Nontuberculous
Radio Address by the President to the Nation: Business Wire - February 23, 2008; WASHINGTON--THE PRESIDENT: Good morning. This Thursday, Laura and I returned from an inspiring visit to Africa. In Benin and Tanzania , we met leaders who are fighting HIV/AIDS and malaria -- and people whose lives have been saved by the generosity of the American people. In Rwanda ,
Indian Prime Minister Meets with Coalition for AIDS Treatment Access (CATA); Assures Action on HIV/AIDS Treatment: Group Presents 10,000 Letters in Support: Business Wire - February 22, 2008; NEW DELHI--A delegation from India s Coalition of AIDS Treatment Access (CATA), a diverse group of civil society partners who engage the collective advocacy interests of all the participating members towards better HIV/AIDS treatment, efficient treatment facilities and efficacy in treatment provision for people living
Teleconference for Media: Christian Perspectives in the Debate on US Global AIDS Policy: Business Wire - February 22, 2008; **12:00 pm ET**, Monday, February 25 Global AIDS Alliance: WHAT: A debate is raging about the next steps the US should take in addressing the global AIDS epidemic. On Wednesday February 27 the US House of Representatives will begin formal consideration of a law that will set US policy on AIDS, TB and malaria for the ne
Congress Retreats on Global AIDS, Says New AHF Ad Campaign: Advertisement Urges Congress to Keep PEPFAR Funding Focus on Lifesaving Medical Treatment: Business Wire - February 22, 2008; WASHINGTON--In response to significantly different proposals by President Bush and Congress for the legislation to reauthorize the President s Emergency Plan for AIDS Relief (PEPFAR), the successful five-year-old US global AIDS program, AIDS Healthcare Foundation (AHF) (www.aidshealth.org) today unveils a new print ad
Anyware Mobile Solutions Helps Geneva Global Fight HIV/AIDS in Africa: Deployment of Mobile Data Collection Technologies Will Speed Assistance under the President's Emergency Plan for AIDS Relief: Business Wire - February 21, 2008; TULSA, Okla.--Geneva Global, the world s leading international philanthropic adviser, has deployed mobile technologies from Anyware Mobile Solutions to improve the collection of demographic and behavioral data in the effort to improve HIV/AIDS care and prevention in Ethiopia and Ivo
Remarks by President Bush and President Kufuor of Ghana in Press Availability: Business Wire - February 20, 2008; ACCRA, Ghana--Osu Castle Accra, Ghana 10:38 A.M. (Local) PRESIDENT KUFUOR: Mr. President, I believe we agreed to expose ourselves to the ladies and gentlemen of the media. (Laughter.) And so we are ready for your questions. PRESIDENT BUSH: Let me have a -- you want me to say something initially, Mr. President? PRES
Hepatitis C - Small-Molecule Antivirals Pave the Way for Triple Therapy: Business Wire - February 20, 2008; NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. Stakeholder Opinions: Hepatitis C - Small-molecule antivirals pave the way for triple therapy To order this report: www.reportlinker.com/p074963/2008/02/Stakeholder-Opinions- Hepa
Press Gaggle by Dana Perino: Business Wire - February 19, 2008; ACCRA, Ghana--Aboard Air Force One En route Accra, Ghana 4:49 P.M. (Local) MS. PERINO: We are on our way to Ghana. The President had a very good day in Kigali. One thing to note, just now he spent about an hour with Sir Bob Geldof, who has been asked by Time Magazine and, I understand, maybe a couple of other publicati
Public Health Service Bureau Changes Name to Ramsell Public Health Rx and Expands Offering with Introduction of New Pharmacy Benefit Management Solution: Pharmacy Benefit Management Solution Designed to Meet Unique Needs of Public Health Sector: Business Wire - February 19, 2008; OAKLAND, Calif.--Public Health Service Bureau today announced that the company has changed its name to Ramsell Public Health Rx to reflect its continued growth, and expansion to providing Pharmacy Benefit Management (PBM) solutions for the public health sector. With the introduction of its new PBM Solution, Ramsell Pub
AGUILAS HIV/AIDS Prevention Services Facing Budget Crisis That Could Cost Lives: AGUILAS Is Only One of Three Latino Gay and Bisexual Organizations in the U.S. Providing HIV Awareness Services: Business Wire - February 19, 2008; SAN FRANCISCO--AGUILAS, a San Francisco-based Latino gay/bisexual non-profit organization offering programs focused on HIV/AIDS awareness, prevention, education, and outreach is holding a press conference Tuesday, February 19, 2008, 11 am PST, at Lesbian Gay Bisexual Transgender Community Center in San Francisco. The o
Assembly Health Committee to Confront California's Response to Sexually Transmitted Disease Epidemic: State and Community Officials Begin Partnership Discussion for Effective STD Control: Business Wire - February 18, 2008; SACRAMENTO--AIDS Healthcare Foundation: WHAT: Assembly Health Hearing on STDs; & Media Availability Community Reaction to Hearing: California s Sexually Transmitted Disease Epidemic: Causes, Costs & Control WHEN: Tuesday, February 19th, 2:00pm - 4:00pm WHERE: STATE CAPITOL BUILDING, Room 4202, SACRAMENTO, CA
Press Gaggle by the First Lady: Business Wire - February 17, 2008; DAR ES SALAAM, Tanzania--Kilimanjaro Hotel Kempinski 3:09 P.M. (Local) MRS. BUSH: Since you all were with the President this morning, I d thought I d come tell you what I did with Madame Kikwete. MS. MCDONOUGH: And Nina could join us. MRS. BUSH: Oh, that s right. You were with us, so you heard everything. Today was a v
Press Briefing by Ambassador Mark Dybul, Global Aids Coordinator, and Press Secretary Dana Perino: Business Wire - February 17, 2008; DAR ES SALAAM, Tanzania--Movenpick Royal Palm Hotel 4:15 P.M. (L) MS. PERINO: Hi, everybody. I will be happy to give you a little bit more about tomorrow and answer other questions after you have a chance to hear from the President s Global Aids Coordinator, who was with the President and Mrs. Bush today. He s traveled
Remarks by the First Lady at the Launch of the National Plan of Action for Orphans and Vulnerable Children: Business Wire - February 17, 2008; DAR ES SALAAM, Tanzania--WAMA Foundation Dar es Salaam, Tanzania 10:46 A.M. (Local) MRS. BUSH: Thank you very much. Congratulations on this National Plan. (Applause.) I also want to thank the singers and the dancers from the Salvation Army for your great performance. Habari zako. (Applause.) Thank you for the warm welc
Event Backgrounder: The President and Mrs. Bush Participate in a Tour of Amana District Hospital and Roundtable on PEPFAR Services: Business Wire - February 17, 2008; DAR ES SALAAM, Tanzania--BACKGROUND The President and Mrs. Bush will participate in a Tour of Amana District Hospital and Roundtable on PEPFAR Services. Amana District Hospital is a municipal hospital located in the Dar es Salaam city center. Amana serves a population of about 1 million people. It also serves as a refe
Remarks by President Bush and President Kikwete of Tanzania in Joint Press Availability: Business Wire - February 17, 2008; DAR ES SALAAM, Tanzania--State House Dar es Salaam, Tanzania 10:29 A.M. (L) PRESIDENT KIKWETE: Mr. President, welcome. I stand before you with a deep sense of gratitude and satisfaction to once again welcome you, Mr. President, and your entire delegation, to our dear country, Tanzania. (Applause.) The outpouring of war
Global AIDS Alliance: Bush in Africa - A Mixed Legacy: Business Wire - February 15, 2008; WASHINGTON--Today President Bush and First Lady Laura Bush leave for a six-day visit to Africa to highlight the Administration s legacy in health, education and economic development. In a speech today, President Bush stated that his Administration has revolutionized the way we approach development by ending what he cal
Warner Bros. Entertainment Joins the "President's Emergency Plan for AIDS Relief" in the Fight Against HIV/AIDS: Studio to Use Marketing and Production Resources to Support HIV Prevention Care and Treatment Programs: Business Wire - February 15, 2008; WASHINGTON & BURBANK, Calif.--Warner Bros. Entertainment today announced a public-private partnership with the President s Emergency Plan for AIDS Relief (PEPFAR) to raise awareness about the global HIV/AIDS pandemic, and to collaborate on prevention efforts. The first product of the partnership between Warner Bros
Remarks by the President and the First Lady on Africa Policy: Business Wire - February 14, 2008; WASHINGTON--Smithsonian National Museum of African Art 10:13 A.M. EST MRS. BUSH: Thank you very much, Mark. I get to speak first and introduce the President. Thank you, Mark, for your efforts to lead our country s efforts to defeat HIV/AIDS. Thank you very, very much for everything you do around the world. This is such
HDNet's Dan Rather Reports Investigates Drug Use and Prostitution in Vancouver, BC: In "A Safe Place to Shoot Up," Dan Rather Examines How the 2010 Winter Olympic Host City Plans to Deal with This Growing Problem - Tuesday, February 19 at 8:00 p.m. ET: Business Wire - February 13, 2008; DALLAS--Next Tuesday s Dan Rather Reports travels to the Downtown-Eastside section of Vancouver, British Columbia - the single poorest neighborhood in Canada and one of the roughest areas in all of North America. In this section of the city, one in three residents is HIV positive. The rate of hepatitis C is 70 percent